pyridinolcarbamate has been researched along with Thrombocytopathy in 2 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komarov, FI | 1 |
| Liusov, VA | 1 |
| Bokarev, IN | 1 |
| Kalendovsky, Z | 1 |
| Austin, J | 1 |
| Steele, P | 1 |
1 trial available for pyridinolcarbamate and Thrombocytopathy
| Article | Year |
|---|---|
[Pharmacological action on the thrombocyte link in hemostasis in the treatment of ischemic heart disease].
Topics: Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary D | 1978 |
1 other study available for pyridinolcarbamate and Thrombocytopathy
| Article | Year |
|---|---|
Increased platelet aggregability in young patients with stroke. Diagnosis and therapy.
Topics: Adult; Aspirin; Blood Coagulation Tests; Blood Platelet Disorders; Cell Survival; Cerebrovascular Di | 1975 |